Summary
Introduction
In humans, it is possible to map the active brain areas cerebellum is one of the brain areas which actively contributes to this phenomenon (Chollet et al., 1991; Weiller et al., 1992) . involved in movements by measuring regional cerebral blood flow (rCBF) changes using single photon emission Parkinson's disease is a model of chronic dysfunction of the human extrapyramidal motor system. PET and SPECT tomography (SPECT) (Sabatini et al., 1993) or PET (Fox et al., 1985; Colebatch et al., 1990; Deiber et al., 1991) . studies have previously shown that the subcortical dopamine deficit of Parkinson's disease induces a functional This approach has been helpful to describe the functional plasticity of the human motor system after stroke recovery deafferentation of the supplementary motor area of the cortex (SMA) (Playford et al., 1992; Rascol et al., 1992) . This (Chollet et al., 1991; Weiller et al., 1992; and in amyotrophic lateral sclerosis (Kew et al., 1993) .
SMA deafferentation can be reversed by dopaminergic drugs like apomorphine (Jenkins et al., 1992; Rascol et al., 1992) The reorganization of multiple motor or motor-related areas acting in parallel appears to constitute the central mechanism and levodopa (Rascol et al., 1994) . The hypothesis tested in this study is based on a model previously reported for patients of brain plasticity when the pyramidal tract is lesioned (Weiller et al., 1995) . Several studies have shown that the with a pyramidal tract deficit, namely that a chronic lesion of the extrapyramidal pathway may affect the function of a stimuli and were performed under conditions of sensory deprivation. motor centre like the cerebellum acting in parallel. Motor The motor task, described previously (Rascol et al., 1992 , activation of the ipsilateral cerebellar hemisphere can be 1994; Sabatini et al., 1993) , consists of sequential finger-tomeasured in normal subjects with SPECT (Sabatini et al., thumb opposition movements in turn lasting for the 4 min 1993) and PET (Jenkins et al., 1994) . Until now, few of the rCBF data acquisition period. Handedness was not neuroimaging data have been produced on motor cerebellar considered in the data analysis because we have previously function in Parkinson's disease because the usual position of demonstrated that this motor task induces symmetrical rCBF the patients' head in the scanner does not allow a full view changes when performed with the dominant or non-dominant of the cerebellum. The aim of the present SPECT study was, hand (Sabatini et al., 1993) . Both groups of Parkinson's therefore, to compare rCBF changes induced by a motor task disease patients were asked to perform the motor task with in the cerebellar hemispheres of normal subjects and akinetic their most affected hand. In case of symmetrical bilateral Parkinson's disease patients receiving on or off their impairment, they were asked to execute the task with their medication.
dominant hand. This last instruction was also given to the normal subjects. rCBF data were then analysed considering cortical and cerebellar regions of interest contralateral and
Material and methods
ipsilateral to the hand which executed the movement.
Subjects
The manner in which each subject performed the motor Forty subjects were included in this study: 28 Parkinson's task was measured using video recordings of the hand disease patients and 12 normal control subjects. All patients movements. This procedure allowed quantification of the were clinically diagnosed as having 'idiopathic' Parkinson's motor task frequency (number of fingers-to-thumb opposidisease according to the UK Brain Bank diagnostic criteria tions per minute) and amplitude (on a 0-3 subjective scale (Gibbs and Lees, 1989) . All patients had a positive and where 0 ϭ no spacing between the thumb and the fingers sustained response to dopaminergic treatments. Patients with and 3 ϭ maximal opening amplitude between the thumb and clinical features suggestive of striatonigral degeneration the finger, i.e. 90°). All subjects practised the motor task (Fearnley and Lees, 1990) , progressive supranuclear palsy until they were able to perform the movement with a stable (Daniel et al., 1995) or associated dementia were excluded. amplitude and frequency. Special efforts were made to arrange Parkinson's disease patients were included only if they the experiment so that the three groups executed the motor suffered from an akinetic-rigid syndrome without a tremor, task in a quantitative similar way. For this purpose, the in order to avoid rCBF signals related to this involuntary Parkinson's disease patients off medication (i.e. those who movement. The 28 Parkinson's disease patients were had the greatest difficulties in executing the motor task divided in two separate groups: in the first group (12 patients because of akinesia) were studied first. They were asked to off medication) levodopa and other antiparkinsonian drugs execute the motor task 'as well as they could with the largest had been withheld for at least 18 h to allow the reappearance possible amplitude and the most regular moderate frequency'. of the parkinsonian symptoms, and in the second group (16 The rCBF measurements were performed when the patients patients on medication) levodopa and other antiparkinsonian had found their best and most stable performance. The mean drugs were not interrupted. No patient on medication suffered frequency and mean amplitude achieved by the Parkinson's from dopa-induced dyskinesia that was scored Ͼ1 (mildly disease patients off medication were then calculated (mean disabled) in Item 33 of the Unified Parkinson's Disease frequency ϭ 43/min and mean amplitude ϭ 1.5 on the 0-3 Rating Scale (UPDRS) (part IV: complications of therapy in scale). The Parkinson's disease patients on medication and the past week) (Fahn et al., 1987) . The two Parkinson's normal control subjects had the capacity to execute the motor disease patient groups (on and off medication) were carefully task more rapidly and with a larger amplitude than the matched in order to avoid relevant demographic, clinical or patients off medication; however, they were instructed to perform the motor task at the same frequency and amplitude therapeutic differences (see Table 1 ).
as that achieved by the Parkinson's disease group which was Informed consent was obtained from all patients and off medication. The rCBF measurements were performed normal subjects, and the project was approved by the when they were able to execute the motor task with the CCPPRB-Toulouse I ethical comittee. appropriate required performance. At the end of the study, the video recordings of all the subjects' hand movements were analysed blind to compare the mean amplitude and
Paradigm design
frequency of the three groups. The absence or presence of Two rCBF measurements were obtained on the same day for movements in the other parts of the body was checked during each subject with a 60 min interval between scans: one the period of data acquisition. measurement was obtained during the execution of a motor task (movement of one hand) and the second while lying quietly (resting state). The chronological order of the two rCBF measurement measurements was randomized across subjects. Motor task
The technique used to measure rCBF has been described previously (Sabatini et al., 1993) . Briefly, rCBF was assessed and resting states were balanced for visual and auditory using SPECT (Tomomatic 64, Medimatic, Copenhagen, (CMϩ0), we drew two symmetrical and lateral 15-pixel regions of interest on each cerebellar hemisphere. The Denmark) and intravenous injection of Xenon (2220 MBq). The mean global flow was measured from data collected cerebellar regions of interest were parallel and separated from the vertical interhemisphere axis by 2 cm. Three regions from three transverse slices simultaneously at 0, 4, and 8 cm above the canthomeatal plane (CM). The rCBF changes were of interest were drawn in Slice 3: one medial anterior region corresponding to the two SMA (12 pixels) and studied in five regions of interest obtained from Slice 1 (CMϩ0) and Slice 3 (CMϩ8) (see Fig. 1 ). We determined two symmetrical and lateral regions (16 pixels each) corresponding to the contralateral and ipsilateral primary the features of the five regions of interest (i.e. their shape, number of pixels and topography) by visual analysis of sensory motor areas (contra-and ipsilateral S1M1). Finally the rCBF data were normalized for the five motor regions of images of the tomographic slices, and by applying known functional anatomy of the motor system and data from an interest using a global factor calculated from the global CBF of the three slices (rCBF at rest/rCBF during the motor task). anatomical stereotaxic atlas (Talairach and Tournoux, 1988) Once these features had been determined, they were recorded
The rCBF value for each region of interest collected during the motor task was multiplied by this factor to eliminate in a Macintosh II microcomputer for image processing. The different regions of interest were then superimposed on each non-specific rCBF changes. Localization of the regions of interest on the SPECT scans were carried out blind. of the corresponding rCBF slices. This method of analysis allowed us to compare regions of interest with the same Considering the limited spatial resolution of our tomography system, the rCBF values in the cortical regions of interest topography, shape and number of pixels in every subject. The features of each region of interest can be described as may only represent the partial value of the specified anatomical regions. The arterial pCO 2 was continuously follows: each pixel measured 3.5ϫ3.5 mm 2 . In Slice 1 recorded using a cutaneous electrode and a pCO 2 monitor change in ipsilateral cerebellar rCBF (ipsilateral to the hand movement) was significantly larger in the Parkinson's disease (Kontron 634, Kontron, Basle, Switzerland). A small blood sample was withdrawn for determination of the packed cell group off medication compared with the two other groups of subjects (P Ͻ 0.02). The percentage change in rCBF in volume. Systolic and diastolic blood pressure were measured at the moment of each rCBF measurement.
the SMA was significantly smaller in the Parkinson's disease group off medication than in the two other groups (P Ͻ 0.001). There were no significant differences between the three groups in terms of percentage changes in rCBF in the
Statistical analysis
The rCBF values were compared between the resting state contra-and ipsilateral S1M1 or in the contralateral cerebellar hemisphere. and the motor task state in the five regions of interest of each group using a paired Student's t test. A comparaison between the three groups of subjects, of the percentage changes in rCBF induced by the execution of the motor task
Discussion
The main finding of our study was that the ipsilateral in the five regions of interest, was performed using a multivariate analysis of variance (MANOVA). A post hoc cerebellar hemisphere was overactive in Parkinson's disease patients who were off their medication when they performed univariate analysis (Duncan test) was examined following a significant F test. Significance was accepted when P Ͻ 0.05. a motor task. This abnormality was not observed in the Parkinson's disease patients who were on medication. We Results are expressed as meanϮSEM.
also confirm that the SMA is underactive in Parkinson's disease patients off medication and that normal SMA activity is restored by dopaminergic treatment. In the resting
Results
There was no significant difference in the frequency and condition, no significant rCBF abnormality was observed in Parkinson's disease patients, either on or off medication. amplitude of the motor task between the three groups (Table  1) . Five Parkinson's disease patients on medication exhibited
The possibility that a methodological artefact could account for the ipsilateral cerebellar overactivity, in the Parkinson's mild bilateral dyskinetic movements during data acquisition. One Parkinson's disease patient off medication had some disease patients who were off medication, must be considered. We made certain that there were no significant differences minor associated movements of the contralateral hand when executing the motor task. There was no significant difference in the way control subjects and Parkinson's disease patients, on or off medication, performed the motor task. We also between the mean global CBF of the three groups of subjects at rest or during the execution of the motor task. The checked that both groups of Parkinson's disease patients had similar demographic, symptomatic and therapeutic features. normalization factor did not differ between the three groups. There was no difference in blood pressure or arterial pCO 2 The limits of the spatial resolution of our tomograph cannot account for this result. SPECT studies of motor activation between the three groups or within the same group from one scan to another. When the subjects were at rest, there were (Rascol et al., 1992 (Rascol et al., , 1994 Sabatini et al., 1993) provide concordant results with comparable PET studies (Deiber no differences in rCBF between the symmetrical regions of interest within each group, and there were no significant interet al., 1991; Jenkins et al., 1992; Playford et al., 1992) . Our tomograph can measure a significant rCBF cerebellar group differences in rCBF when comparing the corresponding regions of interest in the three groups activation in normal subjects performing a similar motor task to that used in this study (Sabatini et al., 1993) . In the present When comparing rCBF data at rest and after activation in each group, the normal subjects and Parkinson's disease protocol, however, no significant activation was recorded in the ipsilateral cerebellar hemisphere of the normal subjects patients on medication exhibited the same patterns of rCBF activation. In these two groups, the execution of the hand because of the relatively low rate and small movement amplitude in the motor task which were matched to the movements induced a significant increase in rCBF in the contralateral S1M1 and in the SMA (see Table 2 ) but not in limited motor skill of the Parkinson's disease patients who were off medication (Sabatini et al., 1993) . The movement the ipsilateral S1M1 or in the cerebellar hemispheres. In contrast, the Parkinson's disease patients off medication must be executed faster and with a larger amplitude to detect a significant cerebellar activation in normal subjects (Sabatini showed a different pattern of activation; the motor task induced a significant rCBF activation in the contralateral et al., 1993). Other observations support the relevance of our results. The cerebellar overactivation was only observed in S1M1 and in the ipsilateral cerebellar hemisphere while no significant signal was recorded in the three other regions of the ipsilateral cerebellar hemisphere, in agreement with known cerebellar functional organization. Moreover, it was interest (see Table 2 ).
When we compared percentage changes in the rCBF in not observed in patients on medication. Cerebellar activation has probably been missed in previous PET studies because the five different regions of interest of the three different groups, the MANOVA showed a significant interaction in such studies on Parkinson's disease patients, rCBF has been measured mainly in the motor cortex and basal ganglia. between group and region of interest (P Ͻ 0.05). A post hoc univariate analysis (Duncan test) showed that the percentage The cerebellum has only been partially imaged in PET studies Ipsilateral cerebellum 65Ϯ2 6 5 Ϯ 2 7 2 Ϯ 3 7 8 Ϯ 4* 64Ϯ2 6 3 Ϯ 2 Contralateral cerebellum 65Ϯ2 6 5 Ϯ 2 7 2 Ϯ 3 7 2 Ϯ 3 6 4 Ϯ 3 6 3 Ϯ 2 Ipsilateral S1M1 58Ϯ3 5 8 Ϯ 2 6 0 Ϯ 3 6 0 Ϯ 3 5 3 Ϯ 2 5 6 Ϯ 2 Contralateral S1M1 58Ϯ2 6 3 Ϯ 2** 59Ϯ3 6 1 Ϯ 3* 55Ϯ2 5 9 Ϯ 3** SMA 63Ϯ2 6 6 Ϯ 3* 64Ϯ4 6 2 Ϯ 4 5 9 Ϯ 3 6 4 Ϯ 3* S1M1 ϭ primary sensorimotor area; SMA ϭ supplementary motor area. *P Ͻ 0.01 and **P Ͻ 0.001 (paired Student's t test, motor activation versus resting condition).
of Parkinson's disease patients, one single slice providing It has been reported from previous clinical observations that cerebellar lesions may improve hypertony in Parkinson's data of the upper cerebellum vermis.
If a technical bias cannot account for our results, then disease patients. For example, surgical dentatectomy as well as cerebellar infarction have been noted to reduce or abolish discussion of a possible pathophysiological mechanism is necessary. rCBF activation in cerebral sensorimotor areas ipsilateral rigidity in Parkinson's disease patients (Toth, 1961; Rivest et al., 1990) . There is no clear explanation for this such as the cerebellum reflects the synaptic activity related both to the efferent motor command and the afferent benefit but a reduction in the activity of the spinal stretch reflex due to the cerebellar lesion has been proposed. This somatosensory feedback information. In a recent study, Jueptner et al. (1996) showed that passive movements activate does not imply, however, that a cerebellar overactivity could contribute to the genesis of parkinsonian rigidity. In fact, the identical parts of the cerebellar hemisphere to almost the same extent as the corresponding active movements, normality of cerebellar rCBF, in the resting condition, in the Parkinson's disease patients who were off medication does underlying the importance of the afferent somatosensory component in the cerebellar activation. There is, however, not support such an hypothesis. Thus, abnormal somatosensory inputs, and parkinsonian no evidence of excessive somatosensory input or sensitivity in Parkinson's disease patients and no overactivation has tremor and rigidity, are unlikely to explain our results. Akinesia is a more attractive explanation because the been observed in other sensorimotor areas like the sensorimotor cortex. Thus, we believe that our findings can cerebellar overactivity was present only in dynamic conditions when akinetic Parkinson's disease patients who were off be explained best by changes in the motor rather than in the somatosensory systems. medication were asked to perform the motor task. Our results could then be interpreted as if Parkinson's disease patients Cerebellar rCBF has been measured using PET in patients with parkinsonian tremor (Deiber et al., 1993) . These authors tried to compensate for the failure of the basal ganglia motor loop by employing alternative motor pathways, involving, showed that the cerebellum contributes to the generation of parkinsonian tremor. Similar conclusions have been reported for example, the cerebellum. In a very recent PET study, Samuel et al. (1996) observed a similar phenomenon in the in patients with essential tremor . However, the design of Deiber et al's (1993) study differed from ours premotor and parietal cortex of Parkinson's disease patients. They suggested, as we do, that the deafferentation of the in two important ways: (i) they studied Parkinson's disease patients in the resting condition, whereas we studied patients striato-mesial frontal projections in Parkinson's disease leads to compensatory overactivity of other motor-related cerebral performing a motor task; (ii) they studied Parkinson's disease patients suffering from a severe resting tremor whereas we areas during sequential finger movements. These authors could not measure rCBF accurately in the cerebellum with excluded such patients in order to avoid any tremor-related rCBF signals. In the resting condition, our Parkinson's disease the PET scanner they used. Conversely, we could not easily differentiate the primary and premotor cortex according to patients who were off medication (without tremor) had slightly, but not significantly higher, mean cerebellar rCBF the spatial resolution of our tomograph, but we easily measured rCBF changes in the cerebellum. It is probable values than the patients on medication and the normal control subjects. This is in agreement with the absence of significant that both studies show the same phenomenon at two different levels, involving the functional adaptation of the cerebellochange in the cerebellar cortex glucose metabolism of MPTP-(1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine-) treated parietal association cortex loop and premotor cortex to the defect of the basal ganglia loop. monkeys (Schwartzman and Alexander, 1985) . Deiber et al's (1993) study and ours are thus different, but complementary.
Anatomically, the basal ganglia and the cerebellar loops are known to have distinct afferent and efferent pathways The cerebellum is probably involved in the genesis of parkinsonian resting tremor. It may play another role when and different motor functions with little, or no, overlap in the primate. The SMA is dominated by thalamic inputs from akinetic Parkinson's disease patients execute a movement. the subnucleus VLo which receives its major inputs from the clear that the 'motor states' of the three cohorts of the present study were not identical. The Parkinson's disease patients on basal ganglia, stressing the importance of the pallido-thalamo-SMA connections (Tanji, 1994) . Conversely, the thalamic medication and the control subjects had to be asked to slow down their natural performance, in order to mimic the subnucleus VPLo is known to receive major inputs from the cerebellar nuclei and to send efferents to the primary motor best that could be achieved by the patients who were off medication. Thus, a different approach to the motor task cortex. There is, however, evidences of overlap between the two systems. Several authors have shown that, in the monkey, may have influenced the levels of cerebellar activation seen in these three groups. Subjects in the three groups were all the SMA, rather than being exclusively connected with the basal ganglia, appears to be organized in a way rather similar taught the task prior to SPECT and we checked that all groups performed the opposition task automatically, even to inferior Area 6, with one sector receiving cerebellar afferents and one sector related to the basal ganglia while distracted. Thus, it is unlikely that the Parkinson's disease patients off medication, although having greater (Wiesendanger and Wiesendanger, 1985; Matelli et al., 1989; Tanji, 1994) . The primary motor cortex and the SMA are motor difficulties than the two other groups, were still learning to master the task during SPECT. Thus, we do not recipients of transthalamic inputs from pallidum, thalamus and cerebellar nuclei, thus supporting the concept that a believe that they required a greater level of cerebellar activation simply because they, unlike the other two groups, mixed subcortical input consisting of weighted contributions from cerebellum, basal ganglia, substantia nigra and might still be acquiring the skill (Frith et al., 1996) . Finally, it is conceivable that neurochemical abnormalities spinothalamic tract is directed to each functional component of the motor cortex (Rouiller et al., 1994) . Additional in the cerebellum of Parkinson's disease patients may also explain an abnormal function of this structure in Parkinson's anatomical convergence exists both in the intralaminar nuclear complex of the thalamus (Jones, 1985) and in the disease. The cerebellar overactivity was not observed in the group of Parkinson's disease patients receiving a magnocellular division of the red nucleus (Kennedy 1990) .
Some authors have already proposed that patients with dopaminergic treatment. This observation suggests that the central dopaminergic deficit is related to this abnormality. Parkinson's disease might use alternative pathways, e.g. via the cerebellum, to compensate the loss of basal ganglia Dopaminergic projections to the cerebellum appear to be quite scarce and no major decrease in cerebellar dopamine (Glickstein and Stein, 1991; Marsden and Obeso, 1994) . It is known that movements driven by external stimuli employ content has been reported in Parkinson's disease (Agid et al., 1989) . There is then little evidence for a direct role of a different cortical routes from those driven by internal decisions, the former using lateral frontal areas while the dopaminergic deficit within the cerebellum in Parkinson's disease. It is more likely that what we observed is the latter use those more medial (Goldberg, 1985; Passingham et al., 1989) . Visual feedback may improve the motor functional consequence of a distant dopaminergic deficit within the basal ganglia or motor cortex. However, Pifl performance in Parkinson's disease patients. Visual input may have access to the motor cortex without traversing the et al (1991) showed that dopamine concentrations were significantly reduced in the cerebellar cortex and dentate basal ganglia, using pontine nuclei and cerebellar relays. This visuo-motor pathway, relaying through the cerebellum, could nucleus of MPTP-treated monkeys. Moreover, noradrenaline and serotonin markers are also known to be reduced in explain why the motor performance of Parkinson's disease patients is improved when operating under visual control the cerebellum of MPTP-treated monkeys and Parkinson's disease patients (Agid et al., 1989; Pifl et al., 1991) . Such (Glickstein and Stein, 1991) . In our experiment, however, subjects were asked to keep their eyes closed when moving abnormalities can provide additional causes of a cerebellar dysfunction and a primary cerebellar dysfunction cannot be the hand and the experiment was conducted under sensory deprivation conditions. Therefore, it is difficult to advocate totally ruled out.
In conclusion, the results presented here suggest that an involvement of such visuocerebellar pathways to explain the cerebellar overactivation observed in the present protocol. cerebellar function is affected by the basal ganglia deficit in Parkinson's disease. We suggest that this finding should be PET studies have shown that the cerebellum is activated when normal subjects are learning a motor task (Jenkins investigated further using PET and functional MRI neuroimaging techniques in humans, and electrophysiological et al., 1994). Brooks (1995) suggested that, according to PET data, the cerebellum could be involved in motor skill neuronal recordings in the primate MPTP model of Parkinson's disease. Our data support the hypothesis that acquisition or in promoting automaticity of movements, while the basal ganglia could instead facililate a required movement in Parkinson's disease patients suffering from a chronic impairment of the basal ganglia motor function, as in stroke by monitoring and optimizing the pattern of muscular activity. The normal subjects and Parkinson's disease patients in the and ALS (amyotrophic lateral sclerosis) patients, the deficit of one motor pathway is being compensated for by the use present study were trained to execute the motor task in advance and there is an attenuation of activation of the of another. This observation in the cerebellum is concordant with similar findings in the parietal and premotor cortices of cerebellum as subjects become more practised (Seitz et al., 1990; Friston et al., 1992; Jenkins et al., 1994) . This previous Parkinson's disease patients (Samuel et al., 1996) . However, the effectiveness of this adaptative strategy remains unclear training may be important in explaining our results. It is major adverse effect upon movement in Parkinson's disease (Marsden and Obeso, 1994) .
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